https://www.transceleratebiopharmainc.com/wp-content/uploads/2020/10/Lung-Cancer-Linnea-Olson-Patient-Story_1.mp4 To kick off 2026, we spoke with industry experts and leaders in the Clinical Research News community about what they expect and look forward to in the new year. More than ever before, artificial intelligence took center stage. Read the full article featuring Allison Cuff Shimooka from Clinical Research News here.
READ MORE
https://www.transceleratebiopharmainc.com/wp-content/uploads/2020/10/Lung-Cancer-Linnea-Olson-Patient-Story_1.mp4 To kick off 2026, we spoke with industry experts and leaders in the Bio-IT World community about what they expect and look forward to in the new year. Read the full article featuring Allison Cuff Shimooka from Bio-It World here.
READ MORE
https://www.transceleratebiopharmainc.com/wp-content/uploads/2020/10/Lung-Cancer-Linnea-Olson-Patient-Story_1.mp4 This is part 2 of my article about predictions for the clinical trials industry in 2026. From my reporting on AI growing pains, site-network shakeups, and the never-ending sponsor–site tension over feasibility and budgets, it’s clear the industry is carrying plenty of unresolved business into the new year. Read the full article featuring Rob…
READ MORE
